search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Saturday 3 July 2021 • Promotional Content


Arresting the silent thief of sight


What is glaucoma?


Specialist clinics Healthcare Innovations 33


Catheter (250 microns in diameter) used to improve drainage in the eye G


laucoma affects over half a million people in the UK. It’s the commonest cause of


irreversible and complete blindness worldwide. Te normal eye is pumped up with fluid to maintain its shape. In glaucoma, the drainage system in the eye becomes blocked and the eye pressure increases. Tis causes damage to the delicate optic nerve, which connects the eye to the brain. Certain risk factors increase the risk of glaucoma such as family history. If a first-degree relative (mother, father or siblings) suffers with the condi- tion, then your risk of developing the condition increases 10-fold to one in five. Te main problem with glaucoma is that in the vast majority it has no early symptoms or warning signs. Patients will often present to hospital eye clinics with advanced glaucoma without any prior warning; therefore it’s critical that all adults over the age of 40 have screening tests done at their optometrist at least once every two years as a minimum and annu- ally if there’s a family history of glau- coma. It’s important to ensure that your tests are done by an experienced and skilled clinician who has access to the latest technology to identify early glaucoma.


It’s critical that all adults over the age of 40 have screening tests done at their optometrist at least once every two years as a minimum


Current treatment options Treatment of glaucoma is designed to lower the eye pressure. Tis is usually in the form of eye drops for the vast majority of patients. Eye drops could come with side effects and simple difficulty in installation. Anyone who has ever used eye drops will tell you that the drop goes just about everywhere except the eye. In the last decade, significant progress has been made in the treatment of glaucoma.


Stents used to improve drainage in the eye


SLT laser surgery Tis is a very good option for the treatment of early glaucoma and is also one of the safest options for lowering eye pressure. In the majority of patients, this will obviate the need for eye drops to control pressure. SLT laser surgery is available at Te Edgbaston Eye Clinic.


Mr Imran Masood


Surgical options Mr Imran Masood, consultant ophthalmic surgeon at Te Edgbaston Eye Clinic and the Birmingham and Midland Eye Centre, is a pioneer in the field of glaucoma surgery having introduced some of these new tech- nologies to the UK. He’s a leader in the use of the iStent and catheter-based interventions for glaucoma control,


which target the natural drainage canal to improve its function and lower eye pressure. Tese minimally invasive operations can be performed quickly and safely under local anaes- thesia with very low risk, compared to conventional options such as trabeculectomy. Mr Masood is also highly experienced in the use of the Preserflo shunt device: a minimally invasive alternative to conventional trabeculectomy, where


surgery of


the natural drainage system can’t be performed. Mr Masood has significant


experience in dealing with complex glaucoma cases using minimally invasive techniques and regularly sees patients from all over the world for second opinions.


For further information, get in touch via the below:


Birmingham — Te Edgbaston Eye Clinic, Harborne T: 0121 605 1884 E: info@medsecadmin.co.uk


Spire Hospital Little Aston T: 0121 446 1811 E: ophthsec@btinternet.com


imranmasood.co.uk


YouTube channel: youtube.com/ user/imranmasood777 Examples of actual surgical procedures carried out by Mr Imran Masood


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44